SP Ventures Exits Brazilian Biotech Firm Bug with Sale to Koppert (em português) 18 December 2017 SP Ventures exited Bug Agentes Biológicos, a Brazilian biotech firm, though a sale to Dutch biochemical company Koppert Biological Systems. (Valor Econômico) A holandesa Koppert fechou a aquisição, por meio…